Product Description
Select Atropine Sulphate Injection IP for a matchless emergency solution against bradycardia and organophosphate poisoning. Manufactured under GMP certified conditions in India, this phenomenal formulation features Atropine Sulphate 0.6 mg/ml in a clear, colorless solution, supplied in valiant Type I glass ampoules. Administered via IV, IM, or SC, it ensures reliability for medical professionals. Grab this regulatory-compliant injection at a discount through verified suppliers. Strict storage and dosing guidelines preserve efficacy, aligning with the highest standards. Empower your hospital or clinic with trusted, allopathic emergency care.
Versatile Medical Emergency Solution
Atropine Sulphate Injection IP is extensively used as an anticholinergic agent suitable for adults and children (as per dosage guidelines). Its principal applications include emergency cardiac care for bradycardia, pre-anesthetic preparation, and as a potent antidote for organophosphorus poisoning. Designed for professional administration in hospitals and clinics, this injectable supports rapid intervention wherever acute pharmacologic management is needed, ensuring optimal outcomes in critical medical scenarios.
Domestic & International Supply Reach
Our Atropine Sulphate Injection IP commands significant market value in the main domestic market of India and is also dispatched across major international export markets. Competitive quotations are provided for bulk orders, ensuring prompt dispatching and continuous supply ability. With reliable logistics partners, we support timely order processing for hospitals, clinics, and emergency care suppliers worldwide, maintaining product availability and compliance with diverse regulatory requirements.
FAQ's of Atropine Sulphate Injection IP:
Q: How is Atropine Sulphate Injection IP administered?
A: Atropine Sulphate Injection IP may be administered intravenously, intramuscularly, or subcutaneously, depending on the urgency and clinical situation. Dosage and route should always be determined by a qualified physician.
Q: What are the primary uses of Atropine Sulphate Injection IP?
A: This injection is mainly indicated for treating bradycardia, serving as a pre-anesthetic medication, and acting as an antidote in cases of organophosphorus poisoning.
Q: When should Atropine Sulphate Injection IP be avoided?
A: Avoid using Atropine Sulphate Injection IP in patients with narrow-angle glaucoma, prostatic hypertrophy, or myasthenia gravis, as these conditions are contraindications.
Q: Where can Atropine Sulphate Injection IP be sourced?
A: This product is available through registered suppliers and traders in India, and can be supplied internationally through authorized export channels. Contact suppliers for a detailed quotation.
Q: What benefits does Atropine Sulphate Injection IP offer to medical professionals?
A: Medical professionals benefit from its rapid, reliable action in emergencies, high-quality manufacturing under GMP standards, and compliance with Indian Pharmacopoeia regulations, ensuring patient safety and clinical effectiveness.
Send Inquiry
Send Inquiry
Send SMS
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese